5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Disminución de errores de medicación Look-Alike Sound-Alike, mediante la implementación de estrategias preventivas en una clínica de III nivel Barranquilla-Colombia Translated title: Decrease in Look-Alike Sound-Alike, medication errors through the implementation of preventive strategies in a third level clinic from Barranquilla-Colombia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen Los medicamentos Look-Alike and Sound-Alike (LASA) son frecuentemente causantes de errores de medicación en el proceso de dispensación, con importantes repercusiones desde el punto de vista humano, asistencial y económico. Objetivo: Determinar la disminución de tasa de estos errores de medicación LASA, posterior a la implementación de estrategias de prevención en una clínica de tercer nivel en Barranquilla, Colombia. Método: La investigación fue de tipo experimental, prospectivo; el periodo de estudio fue de 3 meses (enero-marzo 2021); el criterio de inclusión para el estudio fueron los medicamentos del listado básico de medicamentos LASA y los errores de medicación ocasionados por estos. Se implementaron estrategias de prevención de errores tipo LASA, se cuantificó y comparó los errores de medicación presentados antes y después de la implementación de las estrategias. Resultados: En la etapa de pre-implementación de las estrategias se dispensaron 24.300 medicamentos, entre los cuales se presentaron 80 (0,33%) errores de medicación por medicamentos LASA. En la etapa de post-implementación se dispensaron 23.760 medicamentos, y se presentaron 48 (0,20%) errores de medicación por medicamentos LASA, evidenciando una reducción significativa (P-valor: 0,0366314; IC: 95%). Los medicamentos con mismo principio activo y diferente concentración fueron los de mayor incidencia de errores de medicación en el Servicio Farmacéutico, con 37 errores en la etapa de pre-implementación y 19 errores en la etapa de post-implementación. Conclusión: La reducción de la tasa de errores de medicación fue del 40% al implementar las estrategias propuestas, lo que demuestra su efectividad y su potencial para ofrecer una atención más segura y de mayor calidad a los pacientes, a bajo costo.

          Translated abstract

          Abstract Look-Alike and Sound-Alike (LASA) drugs are frequently the cause of medication errors in the dispensing process, with important repercussions from the human, healthcare and economic point of view. Objective: To determine the decrease in the rate of these LASA medication errors, after the implementation of prevention strategies in a third-level clinic in Barranquilla, Colombia. Method: The research was experimental, prospective; the study period was 3 months (January-March 2021); the inclusion criteria for the study were drugs from the clinic's basic list of drugs that were LASA and the medication errors caused by these. LASA error prevention strategies were implemented; the medication errors presented before and after the implementation of the strategies were quantified and compared. Results: In the pre-implementation stage of the strategies, 24,300 medications were dispensed, among which there were 80 (0.33%) medication errors due to LASA medications. In the post-implementation stage, 23,760 medications were dispensed, and 48 (0.20%) medication errors occurred due to LASA medications, showing a significant reduction (P-valor: 0.0366314; IC: 95%). Medicines with the same active ingredient and different concentrations were those with the highest incidence of medication errors in the Pharmaceutical Service, with 37 errors in the pre-implementation stage and 19 errors in the post-implementation stage. Conclusion: The reduction in the rate of medication errors was 40% after implementing the proposed strategies, which demonstrates their effectiveness and their potential to offer a safer and higher quality care to patients, at low cost.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Look-alike, sound-alike drugs review: include look-alike packaging as an additional safety check.

          Confusion resulting from look-alike and sound-alike drug names and look-alike product packaging can result in potentially harmful medication errors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evaluating the Potential Severity of Look-Alike, Sound-Alike Drug Substitution Errors in Children

            Objective Look-alike, sound-alike (LASA) drug name substitution errors in children may pose potentially severe consequences. Our objective was to determine the degree of potential harm pediatricians ascribe to specific ambulatory LASA drug substitution errors. Methods We developed a unified list of LASA pairs from published sources, removing selected drugs on the basis of preparation type (eg, injectable drugs). Using a modified Delphi method over 3 rounds, 38 practicing pediatricians estimated degree of potential harm that might occur should a patient receive the delivered drug in error and the degree of potential harm that might occur from not receiving the intended drug. Results We identified 3550 published LASA drug pairs. A total of 1834 pairs were retained for the Delphi surveys, and 608 drug pairs were retained for round 3. Final scoring demonstrated that participants were able to identify pairs where the substitutions represented high risk of harm for receiving the delivered drug in error (eg, did not receive methylphenidate/received methadone), high risk of harm for not receiving the intended drug (eg, did not receive furosemide/received fosinopril), and pairs where the potential harm was high from not receiving the intended drug and from erroneously receiving the delivered drug (eg, did not receive albuterol/received labetalol). Conclusions Pediatricians have identified LASA drug substitutions that pose a high potential risk of harm to children. These results will allow future efforts to prioritize pediatric LASA errors that can be screened prospectively in outpatient pharmacies.
              Bookmark
              • Record: found
              • Abstract: not found
              • Book: not found

              Medicamentos de alto riesgo

              F Vitolo (2012)
                Bookmark

                Author and article information

                Journal
                ofil
                Revista de la OFIL
                Rev. OFIL·ILAPHAR
                Organización de Farmacéuticos Ibero-Latinoamericanos (Madrid, Madrid, Spain )
                1131-9429
                1699-714X
                March 2023
                : 33
                : 1
                : 70-78
                Affiliations
                [2] orgnameGrupo de Investigación en Farmacia Asistencial y Farmacología (GIFAF) Colombia
                [1] Barranquilla Atlántico orgnameUniversidad del Atlántico orgdiv1Facultad de Química y Farmacia Colombia darroyo@ 123456mail.uniatlantico.edu.co
                Article
                S1699-714X2023000100013 S1699-714X(23)03300100013
                10.4321/s1699-714x2023000100013
                3742a612-6428-450a-a814-181b36fd0e67

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 22 June 2021
                : 31 May 2021
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 10, Pages: 9
                Product

                SciELO Spain

                Categories
                Originales

                errores de medicación,Pharmacy Service,hospital,behind-the-counter drugs,medication errors,patient safety,Servicio Farmacéutico,medicamentos detrás del mostrador,seguridad del paciente

                Comments

                Comment on this article